Accounts Receivable
AbbVie Accounts Receivable decreased by 0.9% to $12.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from $12.48B to $12.48B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 7.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increasing trend relative to sales may signal collection issues or aggressive revenue recognition, while a decreasing trend suggests efficient cash conversion.
Detailed definition
This represents the balance of money owed to the company by customers for goods or services delivered, net of any estima...
Peer comparison
Varies by industry based on payment cycles; pharmaceutical peers typically have predictable cycles tied to major wholesale contracts.
accounts_receivable_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.91B | $9.28B | $9.98B | $10.73B | $11.24B | $10.74B | $11.25B | $11.47B | $11.49B | $11.41B | $11.16B | $11.95B | $11.72B | $11.47B | $10.92B | $12.48B | $12.64B | $12.77B | $12.59B | $12.48B |
| QoQ Change | — | -6.4% | +7.5% | +7.6% | +4.7% | -4.4% | +4.8% | +1.9% | +0.2% | -0.7% | -2.3% | +7.1% | -1.9% | -2.1% | -4.8% | +14.3% | +1.3% | +1.0% | -1.4% | -0.9% |
| YoY Change | — | — | — | — | +13.3% | +15.8% | +12.8% | +6.9% | +2.3% | +6.2% | -0.9% | +4.1% | +2.0% | +0.5% | -2.1% | +4.4% | +7.8% | +11.3% | +15.3% | +0.0% |
Accounts Receivable at Other Companies
Frequently Asked Questions
- What is AbbVie's accounts receivable?
- AbbVie (ABBV) reported accounts receivable of $12.48B in Q1 2026.
- How has AbbVie's accounts receivable changed year-over-year?
- AbbVie's accounts receivable increased by 0.0% year-over-year, from $12.48B to $12.48B.
- What is the long-term trend for AbbVie's accounts receivable?
- Over 5 years (2020 to 2025), AbbVie's accounts receivable has grown at a 7.4% compound annual growth rate (CAGR), from $8.82B to $12.59B.
- What does accounts receivable mean?
- The amount of money customers owe the company for products already delivered.